Quarterly ResultJul 28, 2026, 05:07 PM
Tilray Brands FY2026 Revenue $915.5M; BrewDog, Lyphe Acquisitions Drive Growth
AI Summary
Tilray Brands reported total net revenue of $915.5 million for the fiscal year ended May 31, 2026, an increase from $821.3 million in FY2025. The company's strategic focus on global expansion was highlighted by the acquisition of BrewDog, transforming its beverage platform, and Lyphe Group, enhancing medical cannabis access in the UK. Tilray also secured a licensing agreement with Carlsberg for US distribution and entered a medical cannabis partnership in Panama, while noting the US cannabis rescheduling.
Key Highlights
- FY2026 total net revenue reached $915.5 million, up from $821.3 million in FY2025.
- Beverage segment revenue grew to $254.0 million in FY2026 from $240.6 million.
- Cannabis segment revenue increased to $268.3 million in FY2026 from $249.0 million.
- Distribution segment revenue rose to $327.2 million in FY2026 from $271.2 million.
- Acquired BrewDog (March-April 2026) to expand global beverage platform.
- Acquired Lyphe Group (April 2026), a UK medical cannabis clinic and digital pharmacy.
- Secured exclusive US licensing agreement with Carlsberg Group starting January 2027.
- Entered strategic partnership for medical cannabis operations in Panama (October 2025).
Price Impact
More from TLRY